Registration Options

Activity Dates: 04/01/2021 - 02/24/2024

Members can access this product for only $45. Log in or Join now!

Target Audience

This course is designed for pharmacists, nurse practitioners or other health care professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

This program is the self-study, enduring version of the pre-meeting workshop from CPNP 2021. With presentations from expert faculty members (Drs. Jeff Bishop and Vicki Ellingrod), case-based learning, and group discussion, novice learners in the area of PGx can build and enhance their understanding of the current state of evidence for incorporating pharmacogenomics into patient care plans. It is clear there has been significant growth in the use of pharmacogenomics (PGx) testing applied to the prescribing of psychiatric medications. Patients and providers may be unfamiliar with PGx tests, including resources available to aid in interpretation, as well as how to effectively communicate with patients and other providers about the reasons to (or not to test) and interpretation of the results. With the event of direct to consumer testing options, providers may also be uncertain of what to do when presented with a testing result, including understanding the evidence behind the results included. Furthermore, providers may not be comfortable counseling patients on PGx results due to their lack of direct experience with the tests. Therefore, this program will be geared toward the novice learner with intent to build and enhance pharmacists’ understanding of the current state of evidence for incorporating pharmacogenomics into patient care plans.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Sign in (or create a FREE account).
  • Register for this course. (sign in first)
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date. (sign in first)
  • Complete the evaluation at the end of the activity. (sign in first)
  • If necessary, complete the post-test retest no later than the closing activity date. (sign in first)
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (sign in first)

Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.

Faculty Information and Disclosures

Jeffrey R. Bishop, PharmD, MS, BCPP, FCCP
Vicki L. Ellingrod, PharmD, FCCP

View biographical information and disclosures

Learning Objectives

  1. Review current evidence behind the use of pharmacogenomics (PGx) testing for patients prescribed psychiatric and neurologic medications.
  2. Discuss the literature regarding the genes/drug pairs commonly included on PGx tests, as well as the guidelines from Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for testing result interpretation.
  3. Interpret PGx testing results and use results to inform therapeutic recommendations.
  4. Demonstrate patient counseling skills regarding communication involving PGx testing.

Continuing Education Credit and Disclosures

Activity Dates: 04/01/2021 - 02/24/2024
ACPE Contact Hours: 3.25
ACPE Number: 0284-0000-21-001-H04-P (Application)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.